Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage diabetes and, more recently, for weight loss
In order to limit GLP-1 costs and prioritize the cohorts most at risk, payers should develop a risk stratification rubric to segment and prioritize patients for GLP-1 weight loss coverage in cases where it is medically necessary and/or where cost of care can be lowered the most
Review your medical history, including pancreatitis, gallbladder disease, kidney issues, thyroid cancer history, pregnancy plans, diabetes medicines, and prior reactions to injectable therapies
Lancet 399 , 394405 (2022)
US$ 21.34
US$ 26.83
US$ 20.74
